We are live on
!
Find out more
APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
Fund managers haven’t disclosed any holdings of APTO yet.
APTO Hedge Fund Activity: Q1 2026 in Review
4 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2026, worth a combined $40K — up 12% from $35.8K a quarter earlier.
Fund positioning in APTO was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 4 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $40K of Aptose Biosciences, Inc. stock for Q1 2026, up 12% quarter-over-quarter.
- 0 funds opened new Aptose Biosciences, Inc. positions in Q1 2026 and 0 closed out.
Based on aggregated 13F filings for Q1 2026.